Management of severe heart failure.
暂无分享,去创建一个
A. Yamada | Y. Ozaki | S. Kato | H. Hishida | Y. Kato | S. Hiramitsu | H. Kimura | S. Morimoto | K. Shiino | K. Miyagishima | K. Mori
[1] Kiyoshi Yoshida,et al. Elevated E/E' predicts prognosis in congestive heart failure patients with preserved systolic function. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[2] T. Yoshikawa,et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[3] Y. Okutani,et al. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[4] Jeroen J. Bax,et al. Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.
[5] I. Takeuchi,et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[6] P. Armstrong,et al. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia , 2008, Circulation.
[7] A. Hirayama,et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2007, The Lancet.
[8] M. Kodama,et al. Characterization of outpatients with isolated diastolic dysfunction and evaluation of the burden in a Japanese community: Sado Heart Failure Study. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[9] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.
[10] G. Filippatos,et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. , 2006, The American journal of medicine.
[11] Eric Boersma,et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. , 2006, European heart journal.
[12] J. Rouleau,et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure , 2006, Circulation.
[13] P. Ponikowski,et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia , 2006 .
[14] S. Ricksten,et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial* , 2004, Critical care medicine.
[15] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[16] D. Silverberg,et al. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. , 2003, Clinical nephrology.
[17] A. Takeshita,et al. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.
[18] S. Ogawa,et al. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group. , 2000, The American journal of cardiology.
[19] D. DeMets,et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. , 1999, The New England journal of medicine.
[20] J T Watson,et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. , 1999, The Annals of thoracic surgery.
[21] J. Almeida. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[22] D. DeMets,et al. A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure , 1998 .
[23] H. Krum,et al. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy , 1998 .
[24] A. Skene,et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.
[25] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[26] H. Imura,et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. , 1987, Circulation.
[27] B. Gersh. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials , 2008 .
[28] W. Frishman,et al. Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure , 2007 .